114 related articles for article (PubMed ID: 23077864)
1. Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2.
Kong WS; Irie T; Yoshida A; Kawabata R; Kadoi T; Sakaguchi T
Hiroshima J Med Sci; 2012 Sep; 61(3):59-67. PubMed ID: 23077864
[TBL] [Abstract][Full Text] [Related]
2. Emerging role of the host restriction factor tetherin in viral immune sensing.
Hotter D; Sauter D; Kirchhoff F
J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of inactive tetherin delGPI mutant inhibits HIV-1 Vpu-mediated antagonism of endogenous tetherin.
Lv M; Wang J; Zhu Y; Wang X; Zuo T; Liu D; Zhang J; Wu J; Zhang H; Kong W; Yu X
FEBS Lett; 2013 Jan; 587(1):37-43. PubMed ID: 23201263
[TBL] [Abstract][Full Text] [Related]
4. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
5. Purification of eukaryotic tetherin/Vpu proteins and detection of their interaction by ELISA.
Lv M; Zhu Y; Wang J; Zhang H; Wang X; Zuo T; Liu D; Zhang J; Wu J; Kong W; Yu X
Protein Expr Purif; 2013 Oct; 91(2):112-8. PubMed ID: 23916489
[TBL] [Abstract][Full Text] [Related]
6. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Neil SJ; Zang T; Bieniasz PD
Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
Fritz JV; Tibroni N; Keppler OT; Fackler OT
Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
[TBL] [Abstract][Full Text] [Related]
8. Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317.
Bolduan S; Votteler J; Lodermeyer V; Greiner T; Koppensteiner H; Schindler M; Thiel G; Schubert U
Virology; 2011 Jul; 416(1-2):75-85. PubMed ID: 21601230
[TBL] [Abstract][Full Text] [Related]
9. Tetherin inhibits prototypic foamy virus release.
Xu F; Tan J; Liu R; Xu D; Li Y; Geng Y; Liang C; Qiao W
Virol J; 2011 May; 8():198. PubMed ID: 21529378
[TBL] [Abstract][Full Text] [Related]
10. Antagonism to human BST-2/tetherin by Sendai virus glycoproteins.
Bampi C; Rasga L; Roux L
J Gen Virol; 2013 Jun; 94(Pt 6):1211-1219. PubMed ID: 23468424
[TBL] [Abstract][Full Text] [Related]
11. Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation.
Lv M; Zhang B; Shi Y; Han Z; Zhang Y; Zhou Y; Zhang W; Niu J; Yu XF
Sci Rep; 2015 Jun; 5():11736. PubMed ID: 26119070
[TBL] [Abstract][Full Text] [Related]
12. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.
Jouvenet N; Neil SJ; Zhadina M; Zang T; Kratovac Z; Lee Y; McNatt M; Hatziioannou T; Bieniasz PD
J Virol; 2009 Feb; 83(4):1837-44. PubMed ID: 19036818
[TBL] [Abstract][Full Text] [Related]
13. Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.
Kuhl BD; Sloan RD; Donahue DA; Liang C; Wainberg MA
Virology; 2011 Sep; 417(2):353-61. PubMed ID: 21757214
[TBL] [Abstract][Full Text] [Related]
14. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.
Radoshitzky SR; Dong L; Chi X; Clester JC; Retterer C; Spurgers K; Kuhn JH; Sandwick S; Ruthel G; Kota K; Boltz D; Warren T; Kranzusch PJ; Whelan SP; Bavari S
J Virol; 2010 Oct; 84(20):10569-80. PubMed ID: 20686043
[TBL] [Abstract][Full Text] [Related]
15. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction.
Le Tortorec A; Willey S; Neil SJ
Viruses; 2011 May; 3(5):520-40. PubMed ID: 21994744
[TBL] [Abstract][Full Text] [Related]
16. High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2.
Zhang Q; Liu Z; Mi Z; Li X; Jia P; Zhou J; Yin X; You X; Yu L; Guo F; Ma J; Liang C; Cen S
Antiviral Res; 2011 Sep; 91(3):321-9. PubMed ID: 21777622
[TBL] [Abstract][Full Text] [Related]
17. Tetherin: holding on and letting go.
Sauter D; Specht A; Kirchhoff F
Cell; 2010 Apr; 141(3):392-8. PubMed ID: 20434978
[TBL] [Abstract][Full Text] [Related]
18. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
Heusinger E; Kluge SF; Kirchhoff F; Sauter D
J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
[TBL] [Abstract][Full Text] [Related]
19. C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles.
Ray G; Schmitt PT; Schmitt AP
J Virol; 2016 Jan; 90(7):3650-60. PubMed ID: 26792745
[TBL] [Abstract][Full Text] [Related]
20. Human BST-2/tetherin inhibits Junin virus release from host cells and its inhibition is partially counteracted by viral nucleoprotein.
Zadeh VR; Urata S; Sakaguchi M; Yasuda J
J Gen Virol; 2020 Jun; 101(6):573-586. PubMed ID: 32375950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
